Pricing Log in Create free account

Advanced Biomed Inc. (ADVB) vs iSpecimen Inc. (ISPC)

Advanced Biomed Inc. and iSpecimen Inc. are both Diagnostics & Research companies. Advanced Biomed Inc. is the larger, with a market value of $3.1M against $2.0M — 1.5× the size. iSpecimen Inc. has negative trailing earnings, so its P/E is not meaningful; Advanced Biomed Inc. trades at 0.3×. Advanced Biomed Inc. has the higher net margin (0.00% vs −2,449.0%) and the lower return on invested capital (−33.4% vs 0.00%). Across the 12 metrics below, Advanced Biomed Inc. leads on 11 and iSpecimen Inc. on 1.

Valuation

Metric ADVB ISPC Diagnostics & Research median
P/E 0.33 n/m 34.52
P/S n/m 2.39 4.24
P/B 0.20 0.64 3.42
Price to free cash flow n/m n/m 33.51
EV/EBITDA n/m 0.08 23.44
EV/Sales n/m (1.47) 5.18
Earnings yield 300.76% (6,581.25%) (1.50%)
Free cash flow yield (185.35%) (973.26%) 0.00%

Profitability

Metric ADVB ISPC Diagnostics & Research median
Gross margin — (108.26%) 48.32%
Operating margin 0.00% (2,020.05%) (5.68%)
Net margin 0.00% (2,449.02%) (4.10%)
Free cash flow margin 0.00% (1,866.61%) 0.00%
Return on equity 84.77% (968.44%) 0.00%
Return on assets 36.47% (170.09%) (6.05%)
Return on invested capital (33.43%) 0.00% 0.00%

Growth

Metric ADVB ISPC Diagnostics & Research median
Revenue growth (TTM) — (92.11%) 8.99%
EPS growth (last fiscal year) 266.56% 87.03% 20.36%
Revenue growth, 5-year CAGR — (25.10%) 7.30%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric ADVB ISPC Diagnostics & Research median
Debt to equity 0.00 0.00 0.01
Current ratio 9.33 0.82 2.27
Net debt to EBITDA 0.06 0.95 0.68

Dividend

Metric ADVB ISPC Diagnostics & Research median
Dividend yield — — 0.67%
Payout ratio — — 0.20

Size

Metric ADVB ISPC Diagnostics & Research median
Market cap 3.14m 2.03m 2.22b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack